AMENDMENT TO LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • March 9th, 2009 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 9th, 2009 Company Industry JurisdictionTHIS AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT (this “Amendment”), is entered into this 21 day of December 2007 (the “Effective Date”) by and between Santaris Pharma A/S, a Danish corporation having its principal place of business at Hørsholm, Denmark (“Santaris”), and Enzon Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at Bridgewater, New Jersey 08807 (“Enzon”). Santaris and Enzon may be referred to herein individually as a “Party” or collectively, as the “Parties”.
AMENDMENT TO LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • October 21st, 2008 • Evivrus, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 21st, 2008 Company Industry JurisdictionTHIS AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT (this “Amendment”), is entered into this 21 day of December 2007 (the “Effective Date”) by and between Santaris Pharma A/S, a Danish corporation having its principal place of business at Hørsholm, Denmark (“Santaris”), and Enzon Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at Bridgewater, New Jersey 08807 (“Enzon”). Santaris and Enzon may be referred to herein individually as a “Party” or collectively, as the “Parties”.